echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > PNAS: Fever can fight cancer, "small diseases keep getting serious" may not be a rumor

    PNAS: Fever can fight cancer, "small diseases keep getting serious" may not be a rumor

    • Last Update: 2021-08-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Historically, there have been many examples of cancer patients who have recovered themselves from death


    Recently, a research team led by Professor Erika L.


    Fever is a common symptom of human inflammation and infection.


    In order to simulate the heating process of the human body in vitro, the researchers used anti-CD3/CD28 to activate purified CD8 + T cells at 37°C and 39°C respectively.


    Exposure to 39 °C will promote CD8 + TE cell function and anabolism

    In addition, CD8+ T cells activated by high temperature will transform from resting naive T cells to fully activated effector T cells, producing cytokines and cytotoxic molecules that can control the growth of pathogens or tumors


    Subsequently, the researchers adopted these activated T cells into myeloid leukemia mice, and they were pleasantly surprised to find that the anti-tumor response in the mice was enhanced, and the survival rate of leukemia mice injected with T cells stimulated at 39°C increased significantly.


    Exposure to 39 °C can improve T cell metabolism and function in the body

    It is well known that mitochondria can regulate the energy level and redox state of cells, and influence the fate of tumor cells through multiple signal transduction pathways, and mitochondrial translation elongation factor 4 (mtEF4) is the "switch" of the process of mitochondrial protein translation.


    Therefore, the researchers re-adoptively transferred 39°C T cells treated with mitochondrial translation inhibitor (Antibiotic tigecycline, TIG) into a mouse model of myeloid leukemia, and found that the 39°C T cells treated with TIG had anti-tumor ability in mice.


    When mitochondrial translation is impaired, the protective anti-tumor effect of CD8 + TE cells exposed to fever temperature disappears

    Note: The original text has been deleted

    Reference materials:

    [1]https://#sec-1

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.